Heart procedure study for specific BIOTRONIK EP products
Part of Heart & circulation clinical trials.
This study collects real-world follow-up information after certain heart procedures that use specific BIOTRONIK equipment. It may help confirm how well these devices work in everyday care and improve future recommendations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a heart electrical (EP) procedure that is either diagnostic or therapeutic
- Your planned procedure must use BIOTRONIK EP products from at least 2 of 3 groups: catheters, external devices, or transseptal sheaths
- The BIOTRONIK product must be used for its intended purpose (as described by the study/doctor)
- You must be able to understand the study and sign written consent
- You must be able and willing to return for follow-up visits at the study site
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a registry (a structured record) of people who get certain heart rhythm or heart device procedures using specific Boston Scientific products. The goal is to track outcomes and help improve how these devices are used in real-world care.
This trial studies how safe and effective a newer type of heart pacing (LBBaP) is when using two specific commercial devices. It may help people who are getting their first permanent pacemaker or heart-resynchronization treatment (CRT) by comparing outcomes after the procedure.
This study looks at whether hospitals can reliably get the imaging catheters used during heart procedures. It may help ensure these supplies are available when needed.
This study uses a special ECG to better tell apart different types of fast heart rhythms in people scheduled for a procedure called ablation. The goal is to improve diagnosis and treatment for conditions like atrial fibrillation and other supraventricular tachycardias.
This study is testing a new type of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) called the CorSky Family. The goal is to see how well it works for people who need a device to help their heart pump properly and prevent dangerous rhythms.
This trial gathers health data from a smartphone app to learn more about heart failure in people with a specific type of implanted heart device. The information will help doctors better understand how to treat and manage heart failure.
Hear when a new Cardiac Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.